Here are relevant reports on : minimal-residual-disease-mrd-market
-
Minimal Residual Disease Market by Product (Kits, Instruments), Technology (PCR, NGS), Application (Leukemia, Lymphoma, Multiple Myeloma, Solid Tumors), End User (Hospitals, Diagnostic Labs, Research Institutes), & Region - Global Forecast to 2029
The global minimal residual disease testing market, valued at US$1.27 billion in 2023, stood at US$1.43 billion in 2024 and is projected to advance at a resilient CAGR of 12.2% from 2024 to 2029, culminating in a forecasted valuation of US$2.55 billion by the end of the period. The market is driven by the growing prevalence of cancer globally and increasing funding from international organizations and governments for cancer prevention programs.
- Published: February 2025
- Price: $ 4950
- TOC Available:
-
Pedicle Screw System Market by Product Type (Monoaxial & Polyaxial Pedicle Screw), Surgery (Open Surgery, Minimal Invasive Surgery), Indication (Spinal Deformities, Spinal Trauma), Application (Thoracolumbar, Cervical Fusion) - Global Forecast to 2023
The global pedicle screw systems market is expected to reach USD 724.23 million by 2023 from USD 538.64 million in 2018, at a CAGR of 6.1%. The major factors driving the growth of this market are the increasing incidence of spinal cord injuries, the growing preference for minimally invasive surgeries, and a rising geriatric population. Key players in the pedicle screw systems market include DePuy Synthesis (US), Globus Medical (US), Zimmer Biomet (US), B. Braun (US), Medtronic (Ireland), and Stryker (US).
- Published: October 2018
- Price: $ 4950
- TOC Available:
-
Soil Testing Equipment Market by End-user Industry (Agriculture, Construction, Environment), Type of Tests (Physical, Residual, Chemical), Site (Lab, On-Site), Degree of Automation (Automatic, Manual), and Region – Global Forecast to 2025
The soil testing equipment market is expected to grow from USD 3.3 billion in 2019 to USD 6.2 billion by 2025, at a compound annual growth rate (CAGR) of 10.8% during the forecast period.Key players in the soil testing equipment market include Agilent Technologies (US), Thermo Fisher Scientific Inc. (US), Merck Group (Germany), PerkinElmer Inc. (US), Controls S.p.A (Italy), LaMotte Company (US), Geotechnical Testing Equipment UK Ltd (UK), Sun Labtek Equipments (I) Pvt. Ltd (India), Martin Lishman Ltd (UK), S.W. Cole (UK), Ele International (UK), Gilson Company Inc. (US), Humboldt Mfg. Co. (US), EIE Instruments Pvt. Ltd (India), Eurofins Scientific (Luxemburg), Alfa Testing Equipment (US), Matest (Italy), M&L Testing Equipments (Canada), and Shambhavi Impex (India), among others. Manufacturers broadly adopted new product developments and acquisitions as their major strategies for the market.
- Published: December 2019
- Price: $ 4950
- TOC Available:
-
Water Quality Sensor Market by Type (Residual Chlorine, TOC, Turbidity, Conductivity, pH, and ORP), by Application (Industrial, Agriculture, Wastewater Management, Drinking Water Treatment, and Aquaculture), and Region – Global Forecast to 2030
Horiba (Japan), Danaher (US), Agilent Technologies (US), Xylem (US), Thermo Fisher Scientific (US), Atlas Scientific (US), Hach Instruments (US), Honeywell (US), and ABB (Switzerland) are some of the players in water quality sensor market.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Poultry Medicine/Pharmaceuticals Market by Animal Type (Chickens, Turkeys, Ducks), Product (Drugs, Vaccines, Feed Additives), Disease Indication (Newcastle disease, Infectious Bursal Disease, Salmonella), Route of Administration - Global Forecast to 2029
The global poultry medicine/pharmaceuticals market, valued at US$4.73 billion in 2023, stood at US$5.01 billion in 2024 and is projected to advance at a resilient CAGR of 5.9% from 2024 to 2029, culminating in a forecasted valuation of US$6.68 billion by the end of the period. The growth of the poultry medicine/pharmaceutical industry can be attributed to the rising global population and consumption of poultry meat and eggs leading to more poultry farming practiced notably in the developing regions where poultry is the cheapest source of protein.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
Peritoneal Dialysis Market by Offering (Peritoneal Dialysis Solution Bags, Machines), Modality (Continuous Ambulatory Peritoneal Dialysis Center(CAPD)), Disease Indication (End-Stage Renal Disease), End User (Hospitals) - Global Forecast to 2029
The global peritoneal dialysis market, valued at US$9.12 billion in 2023, stood at US$9.58 billion in 2024 and is projected to advance at a resilient CAGR of 5.8% from 2024 to 2029, culminating in a forecasted valuation of US$12.70 billion by the end of the period. Market growth in the Asia Pacific is attributed to the rising prevalence of acute kidney diseases, improving healthcare expenditure, and the growing accessibility of dialysis for ESRD treatment.
- Published: February 2025
- Price: $ 4950
- TOC Available:
-
Human Microbiome Manufacturing Services Market by Type (Fermentation & Downstream Processing, Strain Development & Optimization), Disease (Infectious, Gastrointestinal, Endocrine & Metabolic Disease) - Global Forecast to 2031
The global Human Microbiome Manufacturing Services market, valued at US$0.09 billion in 2024, stood at US$0.11 billion in 2025 and is projected to advance at a resilient CAGR of 16.7% from 2025 to 2031, culminating in a forecasted valuation of US$0.27 billion by the end of the period. Growing demand for specialized capabilities, such as anaerobic fermentation, microbial process scale-up, formulation, and fill-finish, is fueling broader adoption of human microbiome manufacturing services.
- Published: December 2025
- Price: $ 4950
- TOC Available:
-
Immunofluorescence Assay Market by Product (Reagent, Instruments, Antibodies, Kits, Consumables & Accessories), Type (Direct, Indirect), Disease (Infectious Disease, Other Diseases), End User (Contract Research Organizations) – Global Forecast to 2026
The immunofluorescence assays market is expected to grow from USD 2.6 billion in 2021 to USD 83.5 billion by 2026, at a compound annual growth rate (CAGR) of 6.0% during the forecast period.Thermo Fisher Scientific Inc (US), Abcam PLC (UK), Bio-Rad Laboratories, Inc (US), PerkinElmer Inc. (US), Merck KGaA (Germany), Werfen Company (Spain), Cell Signaling Technology, Inc. (US), MEDIPAN GmbH (Germany)
- Published: February 2021
- Price: $ 4950
- TOC Available:
-
Europe Peritoneal Dialysis Market by Offering (Peritoneal Dialysis Solution Bags, Machines), Modality (Continuous Ambulatory Peritoneal Dialysis (CAPD)), Disease Indication (End-Stage Renal Disease), End User (Hospitals): Forecast to 2031
The Europe peritoneal dialysis market, valued at USD 2.12 billion in 2025, stood at USD 2.20 billion in 2026 and is projected to advance at a resilient CAGR of 4.3% from 2026 to 2031, culminating in a forecasted valuation of USD 2.72 billion by the end of the period. The market is driven by several factors, such as increasing prevalence of chronic kidney-related diseases, strong demand for home-based dialysis, favorable reimbursement policies, and advancements in automated peritoneal dialysis (PD) systems and remote monitoring technologies.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Conjugate Vaccines Market by Disease (Pneumococcal, DTP, Meningococcal Disease), Type (Monovalent, Multivalent), End User (Adult, Pediatric) - Forecast to 2030
The global conjugate vaccines market, valued at US$15.86 billion in 2024, stood at US$15.25 billion in 2025 and is projected to advance at a resilient CAGR of 7.4% from 2025 to 2030, culminating in a forecasted valuation of US$21.77 billion by the end of the period. The conjugate vaccines market is growing rapidly, driven by the rising prevalence of bacterial infections like pneumococcal, meningococcal, and Hemophilus influenzae type b (Hib), rising government immunization programs and policies, innovations in vaccine technology such as multivalent formulations, increased regulatory approvals for new products, and growing investments in research, development, and international collaborations.
- Published: February 2026
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
